Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

PURPOSE: It is projected that approximately 50,000 new cases of prostate cancer will be diagnosed in 2020 in India. Survival has improved because of the development of effective drugs such as abiraterone acetate, but universal accessibility to treatment is not always possible because of cost constra...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Amol, Tannock, Ian F., Srivastava, Priyanka, Biswas, Bivas, Gupta, Vineet Govinda, Batra, Atul, Bhethanabhotla, Sainath, Pramanik, Raja, Mahindru, Shubh, Tilak, TVSVGK, Das, Chandan Krishna, Mehta, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Special Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113122/
https://www.ncbi.nlm.nih.gov/pubmed/32125899
http://dx.doi.org/10.1200/JGO.19.00341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113122/
https://www.ncbi.nlm.nih.gov/pubmed/32125899
http://dx.doi.org/10.1200/JGO.19.00341

Ejemplares similares